These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5790193)

  • 1. [Conservative therapy of arteriosclerotic vascular damage].
    Deutsch E
    Wien Klin Wochenschr; 1969 Jun; 81(23):421-5. PubMed ID: 5790193
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic effect of pyridylcarbinolic ester of clofibric acid on the changes of the lipid and fibrinolytic picture in arteriosclerotic patients].
    Rugginenti
    Minerva Med; 1974 May; 65(35):1906-16. PubMed ID: 4601840
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of a long-term anticoagulant therapy in patients with arteriosclerosis obliterans compared to a collective group with myocardial infarct].
    Schmidt HH; Heine H; Zimmermann B; Hackenberger F
    Z Gesamte Inn Med; 1971 Oct; 26(20):Suppl 20:275-7. PubMed ID: 5004145
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 6. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
    Cascone A; Lampugnani P
    Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arteriosclerosis].
    Anschütz F
    Z Allgemeinmed; 1969 Nov; 45(31):1461-70. PubMed ID: 4903599
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic therapy of atherosclerosis].
    Lingetti M; Policicchio D; Ciarimboli M; Di Grezia F; Lingetti E; Policicchio F
    Clin Ter; 1979 Oct; 91(2):129-53. PubMed ID: 540478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antithrombotic prophylaxis of the complications of arteriosclerosis obliterans].
    Heine H; Norden K; Heinemann L; Stepanauskas M; Schmidt H
    Kardiologiia; 1981 Aug; 21(8):76-80. PubMed ID: 7289389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attack on many vascular fronts. Atherothrombosis trouble seldom comes alone].
    MMW Fortschr Med; 2004; 146 Suppl 1():4-5. PubMed ID: 15493408
    [No Abstract]   [Full Text] [Related]  

  • 11. [Results of long-term dispensary anticoagulant therapy in patients with myocardial infarct and peripheral arteriosclerosis].
    Heine H; Schmidt H; Jahn E; Kornotzki M
    Z Gesamte Inn Med; 1973 Jan; 28(2):27-30. PubMed ID: 4632545
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the therapy of peripheral arteriosclerosis obliterans].
    Pupita F; Stefanelli G
    Minerva Cardioangiol; 1968 Nov; 16(11):1083-93. PubMed ID: 5707453
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical investigations on long-term activation of fibrinolysis by anabolic steroids.
    Bielawiec M; Bodzenta A; Lukjan H; Kiersnowska-Rogowska B; Kłoczko J; Myśliwiec M; Dabrowski S; Tymiński W; Czestochowska E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):223-9. PubMed ID: 2427405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
    Guglielmi G; Barlattani M
    Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
    [No Abstract]   [Full Text] [Related]  

  • 15. [Conservative treatment of arteriosclerosis obliterans].
    Thiele P
    Z Gesamte Inn Med; 1979 May; 34(9):99-102. PubMed ID: 483943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arteriosclerosis, myocardial infarct and blood lipids, their therapeutic modification by magnesium orotate].
    Villányi P; Votin J; Rahlfs V
    Wien Med Wochenschr; 1970 Jan; 120(5):76-83. PubMed ID: 5513887
    [No Abstract]   [Full Text] [Related]  

  • 17. Report on long term therapy with anticoagulants.
    Owren PA
    Thromb Diath Haemorrh Suppl; 1964; 12():131-2. PubMed ID: 5006807
    [No Abstract]   [Full Text] [Related]  

  • 18. Study of clofibrate in hypercholesterinemic rabbits and in arteriosclerotic subjects-modifications of platelet aggregation and fibrinolysis as related to lipidic fractions.
    Baldoni F; Egge H; Giarola P; Müller H; Cuttin S; Gibelli A; Zilliken F; de Nicola P
    New Istanbul Contrib Clin Sci; 1972 Dec; 10(3):135-8. PubMed ID: 4670445
    [No Abstract]   [Full Text] [Related]  

  • 19. [Principles of conservative therapy of chronic arterial circulatory disorders].
    Heidrich H
    Internist (Berl); 1971 Sep; 12(9):377-85. PubMed ID: 4938931
    [No Abstract]   [Full Text] [Related]  

  • 20. [Conservative therapy of arterial occlusion disease].
    Dembowski U; Nielsen A
    Landarzt; 1967 Jun; 43(17):818-23. PubMed ID: 5616518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.